H.R. 2557: Prostate Cancer Misdiagnosis Elimination Act of 2017

CBO Score

$-7,000,000

Date of Report

Tue October 24th, 2017

CBO Report Details

Legislation Details

115th Congress

To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of certain DNA Specimen Provenance Assay clinical diagnostic laboratory tests.

Sponsor: Rep. Larry Bucshon — R — IN

This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

View the full vote history of this bill on GovTrack.us.

As a registered user, you receive personalized updates to your inbox or dashboard when elected officials vote to spend more of your money. Choose to receive updates daily, weekly, monthly, or as they happen.

JOIN US!

Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

×
+ + HIGH LOW +
+ + HIGH LOW +